Application 080172
- Type
- ANDA
- Sponsor
- ACTAVIS ELIZABETH
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PROPYLTHIOURACIL | PROPYLTHIOURACIL | TABLET;ORAL | 50MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0228-2348 | Propylthiouracil | Propylthiouracil | Actavis Pharma, Inc. | ANDA | Current |
| 0228-2348 | Propylthiouracil | Propylthiouracil | Actavis Pharma, Inc. | ANDA | Current |
| 0228-2348 | Propylthiouracil | Propylthiouracil | Actavis Pharma, Inc. | ANDA | Current |
| 0228-2348 | Propylthiouracil | Propylthiouracil | Actavis Pharma, Inc. | ANDA | Current |
| 0228-2348 | Propylthiouracil | Propylthiouracil | Actavis Pharma, Inc. | ANDA | Current |
| 0615-7583 | propylthiouracil | propylthiouracil | NCS HealthCare of KY, Inc dba Vangard Labs | ANDA | Current |